Oxidative DNA damage in cancer patients: A cause or a consequence of the disease development?

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 531, Issue 1-2, 2003, Pages 177-190

  Olinski, Ryszard ^a   Gackowski, Daniel ^a   Rozalski, Rafal ^a   Foksinski, Marek ^a   Bialkowski, Karol ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cancer; MTH1; Oxidative DNA damage

Indexed keywords

8 HYDROXYGUANINE; ANTIOXIDANT; CELL DNA; IRON; NUCLEOTIDE; URIC ACID; VITAMIN;

CANCER GROWTH; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DNA DAMAGE; ENZYME METABOLISM; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; URINALYSIS; URINARY EXCRETION;

EID: 0345016924     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.07.005     Document Type: Conference Paper

References (114)

1. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat. Res. 275:1992;331-342.
2. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis. 11:1990;1447-1450.
3. Jackson A.L., Loeb L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 477:2001;7-21.
4. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., Loeb L.A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G → T and A → C substitutions. J. Biol. Chem. 267:1992;166-172.
5. Feig D.I., Reid T.M., Loeb L.A. Reactive oxygen species in tumorigenesis. Cancer Res. 54:1994;1890s-1894s.
6. Du M.Q., Carmichael P.L., Phillips D.H. Induction of activating mutations in the human c-Ha-ras-1 proto-oncogene by oxygen free radicals. Mol. Carcinog. 11:1994;170-175.
7. Yu D., Berlin J.A., Penning T.M., Field J. Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem. Res. Toxicol. 15:2002;832-842.
8. Comparison of different methods of measuring 8-oxoguanine as a marker of oxidative DNA damage. European Standards Committee on Oxidative DNA Damage (ESCODD), Free Radic. Res. 32 (2000) 333-341.
9. Inter-laboratory validation of procedures for measuring 8-oxo-7,8-dihydroguanine/8-oxo-7,8-dihydro-2′-deoxyguanosine in DNA, Free Radic. Res. 36 (2002) 239-245.
10. Shigenaga M.K., Gimeno C.J., Ames B.N. Urinary 8-hydroxy-2′- deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9697-9701.
11. Suzuki J., Inoue Y., Suzuki S. Changes in the urinary excretion level of 8-hydroxyguanine by exposure to reactive oxygen-generating substances. Free Radic. Biol. Med. 18:1995;431-436.
12. Cooke M.S., Evans M.D., Herbert K.E., Lunec J. Urinary 8-oxo-2′-deoxyguanosine - source, significance and supplements. Free Radic. Res. 32:2000;381-397.
13. Loft S., Fischer-Nielsen A., Jeding I.B., Vistisen K., Poulsen H.E. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J. Toxicol. Environ. Health. 40:1993;391-404.
14. Loft S., Poulsen H.E. Estimation of oxidative DNA damage in man from urinary excretion of repair products. Acta Biochim. Pol. 45:1998;133-144.
15. Girard P.M., Boiteux S. Repair of oxidized DNA bases in the yeast Saccharomyces cerevisiae. Biochimie. 79:1997;559-566.
16. Dianov G., Bischoff C., Piotrowski J., Bohr V.A. Repair pathways for processing of 8-oxoguanine in DNA by mammalian cell extracts. J. Biol. Chem. 273:1998;33811-33816.
17. Helbock H.J., Beckman K.B., Shigenaga M.K., Walter P.B., Woodall A.A., Yeo H.C., Ames B.N. DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc. Natl. Acad. Sci. U.S.A. 95:1998;288-293.
18. Ravanat J.L., Guicherd P., Tuce Z., Cadet J. Simultaneous determination of five oxidative DNA lesions in human urine. Chem. Res. Toxicol. 12:1999;802-808.
19. Gackowski D., Rozalski R., Roszkowski K., Jawien A., Foksinski M., Olinski R. 8-Oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′- deoxyguanosine levels in human urine do not depend on diet. Free Radic. Res. 35:2001;825-832.
20. Weimann A., Belling D., Poulsen H.E. Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry. Nucleic Acids Res. 30:2002;E7.
21. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 362:1993;709-715.
22. Bialkowski K., Cysewski P., Olinski R. Effect of 2′-deoxyguanosine oxidation at C8 position on N-glycosidic bond stability. Z. Naturforsch. [C.]. 51:1996;119-122.
23. Block G., Patterson B., Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer. 18:1992;1-29.
24. Ames B.N., Gold L.S., Willett W.C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5258-5265.
25. Willett W.C. Diet and health: what should we eat? Science. 264:1994;532-537.
26. Schlotte V., Sevanian A., Hochstein P., Weithmann K.U. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro. Free Radic. Biol. Med. 25:1998;839-847.
27. Sevanian A., Davies K.J., Hochstein P. Conservation of Vitamin C by uric acid in blood. J. Free Radic. Biol. Med. 1:1985;117-124.
28. Duthie S.J., Ma A., Ross M.A., Collins A.R. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res. 56:1996;1291-1295.
29. Collins A.R., Olmedilla B., Southon S., Granado F., Duthie S.J. Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis. 19:1998;2159-2162.
30. Moller P., Loft S. Oxidative DNA damage in human white blood cells in dietary antioxidant intervention studies. Am. J. Clin. Nutr. 76:2002;303-310.
31. Jaruga P., Jaruga B., Gackowski D., Olczak A., Halota W., Pawlowska M., Olinski R. Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. Free Radic. Biol. Med. 32:2002;414-420.
32. Gackowski D., Kruszewsk M., Banaszkiewicz Z., Jawien A., Olinski R. Lymphocyte labile iron pool, plasma iron, transferrin saturation and ferritin levels in colon cancer patients. Acta Biochim. Pol. 49:2002;269-272.
33. B. Halliwell, J.M. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, New York, NY, 1999.
34. Gackowski D., Kruszewski M., Jawien A., Ciecierski M., Olinski R. Further evidence that oxidative stress may be a risk factor responsible for the development of atherosclerosis. Free Radic. Biol. Med. 31:2001;542-547.
35. Gackowski D., Kruszewski M., Bartlomiejczyk T., Jawien A., Ciecierski M., Olinski R. The level of 8-oxo-7,8-dihydro-2′-deoxyguanosine is positively correlated with the size of the labile iron pool in human lymphocytes. J. Biol. Inorg. Chem. 7:2002;548-550.
36. de Valk B., Addicks M.A., Gosriwatana I., Lu S., Hider R.C., Marx J.J. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur. J. Clin. Invest. 30:2000;248-251.
37. Nelson R.L., Davis F.G., Sutter E., Sobin L.H., Kikendall J.W., Bowen P. Body iron stores and risk of colonic neoplasia. J. Natl. Cancer Inst. 86:1994;455-460.
38. Stevens R.G., Graubard B.I., Micozzi M.S., Neriishi K., Blumberg B.S. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer. 56:1994;364-369.
39. Olinski R., Zastawny T., Budzbon J., Skokowski J., Zegarski W., Dizdaroglu M. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett. 309:1992;193-198.
40. Malins D.C., Holmes E.H., Polissar N.L., Gunselman S.J. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer. 71:1993;3036-3043.
41. Okamoto K., Toyokuni S., Uchida K., Ogawa O., Takenewa J., Kakehi Y., Kinoshita H., Hattori-Nakakuki Y., Hiai H., Yoshida O. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int. J. Cancer. 58:1994;825-829.
42. Jaruga P., Zastawny T.H., Skokowski J., Dizdaroglu M., Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett. 341:1994;59-64.
43. Kasprzak K.S., Jaruga P., Zastawny T.H., North S.L., Riggs C.W., Olinski R., Dizdaroglu M. Oxidative DNA base damage and its repair in kidneys and livers of nickel(II)-treated male F344 rats. Carcinogenesis. 18:1997;271-277.
44. Foksinski M., Kotzbach R., Szymanski W., Olinski R. The level of typical biomarker of oxidative stress 8-hydroxy-2′-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor. Free Radic. Biol. Med. 29:2000;597-601.
45. Schwartz L.B., Diamond M.P., Schwartz P.E. Leiomyosarcomas: clinical presentation. Am. J. Obstet. Gynecol. 168:1993;180-183.
46. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319:1988;525-532.
47. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 363:1993;558-561.
48. Rozalski R., Gackowski D., Roszkowski K., Foksinski M., Olinski R. The level of 8-hydroxyguanine, a possible repair product of oxidative DNA damage, is higher in urine of cancer patients than in control subjects. Cancer Epidemiol. Biomarkers Prev. 11:2002;1072-1075.
49. Malins D.C., Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 51:1991;5430-5432.
50. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 358:1995;1-3.
51. Schmielau J., Finn O.J. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 61:2001;4756-4760.
52. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51:1991;794-798.
53. V.T. De Vita Jr., S. Hellman, S.A. Rosenberg, Cancer: Principles & Practice of Oncology, Lippincott Wiliams & Wilkins, Philadelphia, 2001.
54. Dizdaroglu M., Olinski R., Doroshow J.H., Akman S.A. Modification of DNA bases in chromatin of intact target human cells by activated human polymorphonuclear leukocytes. Cancer Res. 53:1993;1269-1272.
55. L.M. Franks, N.M. Teich, Introduction to the Cellular and Molecular Biology of Cancer, Oxford University Press, Oxford, New York, Tokyo, 1997.
56. Ohba M., Shibanuma M., Kuroki T., Nose K. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J. Cell Biol. 126:1994;1079-1088.
57. Kayanoki Y., Fujii J., Suzuki K., Kawata S., Matsuzawa Y., Taniguchi N. Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes. J. Biol. Chem. 269:1994;15488-15492.
58. Peddie C.M., Wolf C.R., McLellan L.I., Collins A.R., Bowen D.T. Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumor necrosis factor-alpha concentration. Br. J. Haematol. 99:1997;625-631.
59. Sekiguchi M., Tsuzuki T. Oxidative nucleotide damage: consequences and prevention. Oncogene. 21:2002;8895-8904.
60. Maki H., Sekiguchi M. MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature. 355:1992;273-275.
61. Shibutani S., Takeshita M., Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature. 349:1991;431-434.
62. Pavlov Y.I., Minnick D.T., Izuta S., Kunkel T.A. DNA replication fidelity with 8-oxodeoxyguanosine triphosphate. Biochemistry. 33:1994;4695-4701.
63. Purmal A.A., Kow Y.W., Wallace S.S. 5-Hydroxypyrimidine deoxynucleoside triphosphates are more efficiently incorporated into DNA by exonuclease-free Klenow fragment than 8-oxopurine deoxynucleoside triphosphates. Nucleic Acids Res. 22:1994;3930-3935.
64. Miller H., Prasad R., Wilson S.H., Johnson F., Grollman A.P. 8-oxodGTP incorporation by DNA polymerase beta is modified by active-site residue Asn279. Biochemistry. 39:2000;1029-1033.
65. Minnick D.T., Pavlov Y.I., Kunkel T.A. The fidelity of the human leading and lagging strand DNA replication apparatus with 8-oxodeoxyguanosine triphosphate. Nucleic Acids Res. 22:1994;5658-5664.
66. Kamath-Loeb A.S., Hizi A., Kasai H., Loeb L.A. Incorporation of the guanosine triphosphate analogs 8-oxo-dGTP and 8-NH2-dGTP by reverse transcriptases and mammalian DNA polymerases. J. Biol. Chem. 272:1997;5892-5898.
67. Inoue M., Kamiya H., Fujikawa K., Ootsuyama Y., Murata-Kamiya N., Osaki T., Yasumoto K., Kasai H. Induction of chromosomal gene mutations in Escherichia coli by direct incorporation of oxidatively damaged nucleotides. New evaluation method for mutagenesis by damaged DNA precursors in vivo. J. Biol. Chem. 273:1998;11069-11074.
68. Einolf H.J., Schnetz-Boutaud N., Guengerich F.P. Steady-state and pre-steady-state kinetic analysis of 8-oxo-7,8-dihydroguanosine triphosphate incorporation and extension by replicative and repair DNA polymerases. Biochemistry. 37:1998;13300-13312.
69. Treffers H.P., Spinelli V., Belser N.O.A. A factor (or mutator gene) influencing mutation rates in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 40:1954;1064-1071.
70. Yanofsky C., Cox E.C., Horn V. The unusual mutagenic specificity of an E. coli mutator gene. Proc. Natl. Acad. Sci. U.S.A. 55:1966;274-281.
71. Schaaper R.M., Dunn R.L. Escherichia coli mutT mutator effect during in vitro DNA synthesis. Enhanced A.G. replicational errors. J. Biol. Chem. 262:1987;16267-16270.
72. Akiyama M., Horiuchi T., Sekiguchi M. Molecular cloning and nucleotide sequence of the mutT mutator of Escherichia coli that causes A:T to C:G transversion. Mol. Gen. Genet. 206:1987;9-16.
73. Bhatnagar S.K., Bessman M.J. Studies on the mutator gene, purification of the gene product, and identification of a novel nucleoside triphosphatase. J. Biol. Chem. 263:1988;8953-8957.
74. Bhatnagar S.K., Bullions L.C., Bessman M.J. Characterization of the mutT nucleoside triphosphatase of Escherichia coli. J. Biol. Chem. 266:1991;9050-9054.
75. Weber D.J., Bhatnagar S.K., Bullions L.C., Bessman M.J., Mildvan A.S. NMR and isotopic exchange studies of the site of bond cleavage in the MutT reaction. J. Biol. Chem. 267:1992;16939-16942.
76. Tajiri T., Maki H., Sekiguchi M. Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli. Mutat. Res. 336:1995;257-267.
77. Tassotto M.L., Mathews C.K. Assessing the metabolic function of the MutT 8-oxodeoxyguanosine triphosphatase in Escherichia coli by nucleotide pool analysis. J. Biol. Chem. 277:2002;15807-15812.
78. Nakabeppu Y. Molecular genetics and structural biology of human MutT homolog, MTH1. Mutat. Res. 477:2001;59-70.
79. Sakumi K., Furuichi M., Tsuzuki T., Kakuma T., Kawabata S., Maki H., Sekiguchi M. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J. Biol. Chem. 268:1993;23524-23530.
80. Kakuma T., Nishida J., Tsuzuki T., Sekiguchi M. Mouse MTH1 protein with 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-triphosphatase activity that prevents transversion mutation. cDNA cloning and tissue distribution. J. Biol. Chem. 270:1995;25942-25948.
81. Cai J.P., Kakuma T., Tsuzuki T., Sekiguchi M. cDNA and genomic sequences for rat 8-oxo-dGTPase that prevents occurrence of spontaneous mutations due to oxidation of guanine nucleotides. Carcinogenesis. 16:1995;2343-2350.
82. Mo J.Y., Maki H., Sekiguchi M. Hydrolytic elimination of a mutagenic nucleotide, 8-oxodGTP, by human 18-kilodalton protein: sanitization of nucleotide pool. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11021-11025.
83. Bialkowski K., Bialkowska A., Anderson L.M., Kasprzak K.S. Higher activity of 8-oxo-2′-deoxyguanosine 5′-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) coincides with lower background levels of 8-oxo-2′-deoxyguanosine in DNA of fetal compared with maternal mouse organs. Free Radic. Biol. Med. 27:1999;90-94.
84. Bialkowski K., Bialkowska A., Kasprzak K.S. Cadmium(II), unlike nickel(II), inhibits 8-oxo-dGTPase activity and increases 8-oxo-dG level in DNA of the rat testis, a target organ for cadmium(II) carcinogenesis. Carcinogenesis. 20:1999;1621-1624.
85. Bialkowski K., Kasprzak K.S. A novel assay of 8-oxo-2′- deoxyguanosine 5′-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) activity in cultured cells and its use for evaluation of cadmium(II) inhibition of this activity. Nucleic Acids Res. 26:1998;3194-3201.
86. Bialkowski K., Kasprzak K.S. Activity of the antimutagenic enzyme 8-oxo-2′-deoxyguanosine 5′-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) in cultured chinese hamster ovary cells: effects of cell cycle, proliferation rate, and population density. Free Radic. Biol. Med. 28:2000;337-344.
87. Furuichi M., Yoshida M.C., Oda H., Tajiri T., Nakabeppu Y., Tsuzuki T., Sekiguchi M. Genomic structure and chromosome location of the human mutT homologue gene MTH1 encoding 8-oxo-dGTPase for prevention of A:T to C:G transversion. Genomics. 24:1994;485-490.
88. Oda H., Nakabeppu Y., Furuichi M., Sekiguchi M. Regulation of expression of the human MTH1 gene encoding 8-oxo-dGTPase. Alternative splicing of transcription products. J. Biol. Chem. 272:1997;17843-17850.
89. Oda H., Taketomi A., Maruyama R., Itoh R., Nishioka K., Yakushiji H., Suzuki T., Sekiguchi M., Nakabeppu Y. Multi-forms of human MTH1 polypeptides produced by alternative translation initiation and single nucleotide polymorphism. Nucleic Acids Res. 27:1999;4335-4343.
90. Porter D.W., Yakushiji H., Nakabeppu Y., Sekiguchi M., Fivash M.J. Jr., Kasprzak K.S. Sensitivity of Escherichia coli (MutT) and human (MTH1) 8-oxo-dGTPases to in vitro inhibition by the carcinogenic metals, nickel(II), copper(II), cobalt(II) and cadmium(II). Carcinogenesis. 18:1997;1785-1791.
91. Fujikawa K., Kamiya H., Yakushiji H., Fujii Y., Nakabeppu Y., Kasai H. The oxidized forms of dATP are substrates for the human MutT homologue, the hMTH1 protein. J. Biol. Chem. 274:1999;18201-18205.
92. Fujikawa K., Kamiya H., Yakushiji H., Nakabeppu Y., Kasai H. Human MTH1 protein hydrolyzes the oxidized ribonucleotide, 2-hydroxy-ATP. Nucleic Acids Res. 29:2001;449-454.
93. Hayakawa H., Hofer A., Thelander L., Kitajima S., Cai Y., Oshiro S., Yakushiji H., Nakabeppu Y., Kuwano M., Sekiguchi M. Metabolic fate of oxidized guanine ribonucleotides in mammalian cells. Biochemistry. 38:1999;3610-3614.
94. Fujikawa K., Yakushiji H., Nakabeppu Y., Suzuki T., Masuda M., Ohshima H., Kasai H. 8-Chloro-dGTP, a hypochlorous acid-modified nucleotide, is hydrolyzed by hMTH1, the human MutT homolog. FEBS Lett. 512:2002;149-151.
95. Kang D., Nishida J., Iyama A., Nakabeppu Y., Furuichi M., Fujiwara T., Sekiguchi M., Takeshige K. Intracellular localization of 8-oxo-dGTPase in human cells, with special reference to the role of the enzyme in mitochondria. J. Biol. Chem. 270:1995;14659-14665.
96. Kasprzak K.S., Nakabeppu Y., Kakuma T., Sakai Y., Tsuruya K., Sekiguchi M., Ward J.M., Diwan B.A., Nagashima K., Kasprzak B.H. Intracellular distribution of the antimutagenic enzyme MTH1 in the liver, kidney and testis of F344 rats and its modulation by cadmium. Exp. Toxicol. Pathol. 53:2001;325-335.
97. Okamoto K., Toyokuni S., Kim W.J., Ogawa O., Kakehi Y., Arao S., Hiai H., Yoshida O. Overexpression of human mutT homologue gene messenger RNA in renal-cell carcinoma: evidence of persistent oxidative stress in cancer. Int. J. Cancer. 65:1996;437-441.
98. Okochi E., Ichimura S., Sugimura T., Ushijima T. The absence of Mth1 inactivation and DNA polymerase kappa overexpression in rat mammary carcinomas with frequent A:T to C:G transversions. Jpn. J. Cancer Res. 93:2002;501-506.
99. Kennedy C.H., Cueto R., Belinsky S.A., Lechner J.F., Pryor W.A. Overexpression of hMTH1 mRNA: a molecular marker of oxidative stress in lung cancer cells. FEBS Lett. 429:1998;17-20.
100. Hibi K., Liu Q., Beaudry G.A., Madden S.L., Westra W.H., Wehage S.L., Yang S.C., Heitmiller R.F., Bertelsen A.H., Sidransky D., Jen J. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res. 58:1998;5690-5694.
101. Wani G., Milo G.E., D'Ambrosio S.M. Enhanced expression of the 8-oxo-7,8-dihydrodeoxyguanosine triphosphatase gene in human breast tumor cells. Cancer Lett. 125:1998;123-130.
102. Meyer F., Fiala E., Westendorf J. Induction of 8-oxo-dGTPase activity in human lymphoid cells and normal fibroblasts by oxidative stress. Toxicology. 146:2000;83-92.
103. Kim H.N., Morimoto Y., Tsuda T., Ootsuyama Y., Hirohashi M., Hirano T., Tanaka I., Lim Y., Yun I.G., Kasai H. Changes in DNA 8-hydroxyguanine levels, 8-hydroxyguanine repair activity, and hOGG1 and hMTH1 mRNA expression in human lung alveolar epithelial cells induced by crocidolite asbestos. Carcinogenesis. 22:2001;265-269.
104. Kasprzak K.S., Bialkowski K. Inhibition of antimutagenic enzymes, 8-oxo-dGTPases, by carcinogenic metals. Recent developments. J. Inorg. Biochem. 79:2000;231-236.
105. Tsuzuki T., Egashira A., Kura S. Analysis of MTH1 gene function in mice with targeted mutagenesis. Mutat. Res. 477:2001;71-78.
106. Tsuzuki T., Egashira A., Igarashi H., Iwakuma T., Nakatsuru Y., Tominaga Y., Kawate H., Nakao K., Nakamura K., Ide F., Kura S., Nakabeppu Y., Katsuki M., Ishikawa T., Sekiguchi M. Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc. Natl. Acad. Sci. U.S.A. 98:2001;11456-11461.
107. Egashira A., Yamauchi K., Yoshiyama K., Kawate H., Katsuki M., Sekiguchi M., Sugimachi K., Maki H., Tsuzuki T. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes. DNA Rep. (Amst.). 1:2002;881-893.
108. Colussi C., Parlanti E., Degan P., Aquilina G., Barnes D., Macpherson P., Karran P., Crescenzi M., Dogliotti E., Bignami M. The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool. Curr. Biol. 12:2002;912-918.
109. Hayakawa H., Taketomi A., Sakumi K., Kuwano M., Sekiguchi M. Generation and elimination of 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-triphosphate, a mutagenic substrate for DNA synthesis, in human cells. Biochemistry. 34:1995;89-95.
110. K. Bialkowski, Metabolism of 8-oxoguanine derivatives, Ph.D. dissertation, The Ludwik Rudygier Medical University, Bydgoszcz, Poland, 1997.
111. M. Dizdaroglu, Mechanism of free radical damage to DNA, in: O.I. Aruoma, B. Halliwell (Eds.), DNA and Free Radicals: Techniques, Mechanisms & Applications, OICA International, Saint Lucia, London, 1998, pp. 3-26.
112. Olinski R., Gackowski D., Foksinski M., Rozalski R., Roszkowski K., Jaruga P. Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome(1). Free Radic. Biol. Med. 33:2002;192-200.
113. Benhar M., Engelberg D., Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 3:2002;420-425.
114. Gackowski D., Banaszkiewicz Z., Rozalski R., Jawien A., Olinski R. Persistent oxidative stress in colorectal carcinoma patients. Int. J. Cancer. 101:2002;395-397.